Terms: = Uterine cancer AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP AND Staging
13 results:
1. The analysis of preoperative or intraoperative factors in predicting the escalation of surgical pathological staging of patients with clinical stage I endometrioid carcinoma: A retrospective clinical study.
Li N; Chen Q; Li B
Medicine (Baltimore); 2024 Mar; 103(11):e37465. PubMed ID: 38489719
[TBL] [Abstract] [Full Text] [Related]
2. Contrast-Enhanced Ultrasonography for Transabdominal and Transrectal Ultrasound in staging Cervical cancer: A Reliability Study.
Zhang J; Xiang JD; Jia C; Du LF; Li F
Ultrasound Med Biol; 2023 Oct; 49(10):2283-2290. PubMed ID: 37495499
[TBL] [Abstract] [Full Text] [Related]
3. Construction and validation of a prognostic model for stage IIIC endometrial cancer patients after surgery.
Yang XL; Huang H; Kou LN; Lai H; Chen XP; Wu DJ
Eur J Surg Oncol; 2022 May; 48(5):1173-1180. PubMed ID: 34972620
[TBL] [Abstract] [Full Text] [Related]
4. Invasion Patterns of Metastatic Extrauterine High-grade Serous Carcinoma With BRCA Germline Mutation and Correlation With Clinical Outcomes.
Hussein YR; Ducie JA; Arnold AG; Kauff ND; Vargas-Alvarez HA; Sala E; Levine DA; Soslow RA
Am J Surg Pathol; 2016 Mar; 40(3):404-9. PubMed ID: 26574845
[TBL] [Abstract] [Full Text] [Related]
5. Germline Mutations of brca1 and BRCA2 in Korean Ovarian cancer Patients: Finding Founder Mutations.
Choi MC; Heo JH; Jang JH; Jung SG; Park H; Joo WD; Lee C; Lee JH; Lee JM; Hwang YY; Kim SJ
Int J Gynecol Cancer; 2015 Oct; 25(8):1386-91. PubMed ID: 26402875
[TBL] [Abstract] [Full Text] [Related]
6. Hypermethylation of RAD51L3 and XRCC2 genes to predict late toxicity in chemoradiotherapy-treated cervical cancer patients.
Paulíková S; Chmelařová M; Petera J; Palička V; Paulík A
Folia Biol (Praha); 2013; 59(6):240-5. PubMed ID: 24485306
[TBL] [Abstract] [Full Text] [Related]
7. The risk of diagnostic hysteroscopy in women with endometrial cancer.
Soucie JE; Chu PA; Ross S; Snodgrass T; Wood SL
Am J Obstet Gynecol; 2012 Jul; 207(1):71.e1-5. PubMed ID: 22621816
[TBL] [Abstract] [Full Text] [Related]
8. The rate of the predominant Jewish mutations in the brca1, BRCA2, MSH2 and MSH6 genes in unselected Jewish endometrial cancer patients.
Barak F; Milgrom R; Laitman Y; Gemer O; Rabinovich A; Piura B; Anteby E; Baruch GB; Korach J; Friedman E
Gynecol Oncol; 2010 Dec; 119(3):511-5. PubMed ID: 20850175
[TBL] [Abstract] [Full Text] [Related]
9. Endometrial cancer surgery costs: robot vs laparoscopy.
Holtz DO; Miroshnichenko G; Finnegan MO; Chernick M; Dunton CJ
J Minim Invasive Gynecol; 2010; 17(4):500-3. PubMed ID: 20547112
[TBL] [Abstract] [Full Text] [Related]
10. Is adjuvant therapy necessary for stage IA and IB uterine papillary serous carcinoma and clear cell carcinoma after surgical staging?
Kwon JS; Abrams J; Sugimoto A; Carey MS
Int J Gynecol Cancer; 2008; 18(4):820-4. PubMed ID: 17892450
[TBL] [Abstract] [Full Text] [Related]
11. Surgical advances in the treatment of ovarian cancer.
Li AJ; Karlan BY
Hematol Oncol Clin North Am; 2003 Aug; 17(4):945-56. PubMed ID: 12959184
[TBL] [Abstract] [Full Text] [Related]
12. A case of glassy cell carcinoma of the uterine cervix effectively responding to chemotherapy with paclitaxel and carboplatin.
Hirashima Y; Kobayashi H; Nishiguchi T; Miura K; Kanayama N
Anticancer Drugs; 2001 Aug; 12(7):627-30. PubMed ID: 11487720
[TBL] [Abstract] [Full Text] [Related]
13. Continuous infusion of carboplatin during conventional radiotherapy treatment in advanced squamous carcinoma of the cervix uteri IIB-IIIB (UICC). A phase I/II and pharmacokinetic study.
Micheletti E; La Face B; Bianchi E; Cagna E; Apostoli P; Ruggeri G; Verardi R; Sartori E
Am J Clin Oncol; 1997 Dec; 20(6):613-20. PubMed ID: 9391552
[TBL] [Abstract] [Full Text] [Related]
